PMDA — authorised 25 December 1998
- Marketing authorisation holder: Asahi Kasei
- Status: approved
PMDA authorised Flivas on 25 December 1998
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 25 December 1998.
Asahi Kasei holds the Japanese marketing authorisation.